Column Group LLC is an institution, managing $81.0M across 5 long positions as of Q3 2025 with 100% Healthcare concentration, with only 5 positions, and 52% allocation to ORIC.
Largest long holdings in Column Group LLC's portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $42.5M | 52.48% | — | 3.65% 3.5M shares | |
Biotechnology Healthcare | $19.3M | 23.88% | — | 17.50% 1.5M shares | |
Biotechnology Healthcare | $14.9M | 18.35% | — | 5.77% 9.4M shares | |
Biotechnology Healthcare | $4.3M | 5.29% | -$30.0M Sold | 1.00% 166.1K shares | |
Biotechnology Healthcare | $2.1K | 0.00% | — | 0.00% 46.0 shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Column Group LLC's latest filing
| Position | Shares Δ |
|---|---|
| No increased positions | |
| Position | Shares Δ |
|---|---|
-87.5% |
Portfolio insights and performance metrics for Column Group LLC
We use cookies for analytics. See our Privacy and Cookie Policy.